CMS’ final physician payment rule for 2019: 6 things to know
(By Ayla Ellison for Becker’s Hospital Review) CMS issued its annual update to the Medicare Physician Fee Schedule Nov. 1,
Read More
This group of lawmakers has a new plan to bring down insulin prices, and it takes clear aim at drug makers
(By Nicholas Florko for STAT) WASHINGTON — A bipartisan group of more than 290 lawmakers is throwing its support behind
Read MoreMajority of Medicare beneficiaries want caps on drug costs
According to survey results from eHealth, 83 percent of Medicare beneficiaries believe the best way to ensure the future of
Read MoreGuide for avoiding surprise medical bills released
(By Kelly Gooch for Becker’s Hospital Review) The Healthcare Financial Management Association has developed a downloadable guide to help patients
Read MoreCMS says it will recoup $1B in improper Medicare payments by 2020
(By Morgan Haefner for Becker’s Hospital Review) CMS said it is poised to claw back $1 billion from Medicare Advantage
Read MoreNew Heart Drug Spotlights Troubling Trends In Drug Marketing
(By Shefali Luthra for Kaiser Health News) At the end of September, Amarin Corp. teased some early findings for Vascepa,
Read MoreLooking For ACA Health Insurance For 2019? Here’s What To Expect
(By Alison Kodjak for NPR) It’s time for consumers who buy their own health insurance to start shopping for policies
Read MoreBillions In ‘Questionable Payments’ Went To California’s Medicaid Insurers And Providers
(By Chad Terhune for California Healthline produced by Kaiser Health News) California’s Medicaid program made at least $4 billion in
Read MoreIn Search Of Insurance Savings, Consumers Can Get Unwittingly Wedged Into Narrow-Network Plans
(By Steven Findlay for Kaiser Health News) As a breast cancer survivor, Donna Catanuchi said she knows she can’t go
Read MorePricey Precision Medicine Often Financially Toxic For Cancer Patients
(By Liz Szabo for Kaiser Health News) When Kristen Kilmer was diagnosed with incurable breast cancer at age 38, her
Read More